Download or read book WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention written by World Health Organization and published by World Health Organization. This book was released on 2021-07-06 with total page 115 pages. Available in PDF, EPUB and Kindle. Book excerpt: This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements. Among the 23 recommendations, 6 are identical for both the general population of women and for women living with HIV and 12 are different and specific for each population. Among the 7 good practice statements, 3 are identical for both the general population of women and for women living with HIV and 2 are different and specific for each population.
Download or read book WHO guideline for screening and treatment of cervical pre cancer lesions for cervical cancer prevention written by World Health Organization and published by World Health Organization. This book was released on 2024-06-05 with total page 65 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this publication, recommendations for the Use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV) are presented. Dual-stain cytology can be used as a triage test in cervical “screen, triage and treat" algorithms for cancer prevention. It is performed on liquid-based cytology (LBC) slides (not on conventional Pap smears) to detect the presence of two proteins: p16 and Ki-67. Recommendation for the general population of women: In a screen, triage and treat approach using HPV Nucleic Acid Tests (NATs) as the primary screening test among the general population of women, WHO suggests using partial genotyping, colposcopy, VIA, cytology or dual-stain cytology to triage women after a positive HPV NATs result. When providing dual-stain cytology to triage women after a positive HPV NAT, WHO suggests: using samples collected by the health worker; and retesting with HPV NATs 24 months after a negative dual-stain cytology result. These are conditional recommendations based on low-certainty evidence for dual-stain cytology as a triage test. No recommendation was made for using dual-stain cytology to triage women living with HIV after a positive HPV DNA test, because evidence on the outcomes of using dual-stain cytology applicable to this population was minimal.
Download or read book WHO guideline for screening and treatment of cervical pre cancer lesions for cervical cancer prevention written by World Health Organization and published by World Health Organization. This book was released on 2021-12-17 with total page 63 pages. Available in PDF, EPUB and Kindle. Book excerpt: This current guideline delivers the initial output of the second phase of the guideline update: recommendations for the use of HPV mRNA (messenger ribonucleic acid) tests for screening to detect cervical pre-cancer and prevent cervical cancer.
Download or read book WHO Guideline for Screening and Treatment of Cervical Pre cancer Lesions for Cervical Cancer Prevention written by World Health Organization and published by . This book was released on 2021 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Comprehensive Cervical Cancer Control written by World Health Organization and published by World Health Organization. This book was released on 2006 with total page 284 pages. Available in PDF, EPUB and Kindle. Book excerpt: Most women who die from cervical cancer, particularly in developing countries, are in the prime of their life. They may be raising children, caring for their family, and contributing to the social and economic life of their town or village. Their death is both a personal tragedy, and a sad and unnecessary loss to their family and their community. Unnecessary, because there is compelling evidence, as this Guide makes clear, that cervical cancer is one of the most preventable and treatable forms of cancer, as long as it is detected early and managed effectively. Unfortunately, the majority of women in developing countries still do not have access to cervical cancer prevention programmes. The consequence is that, often, cervical cancer is not detected until it is too late to be cured. An urgent effort is required if this situation is to be corrected. This Guide is intended to help those responsible for providing services aimed at reducing the burden posed by cervical cancer for women, communities and health systems. It focuses on the knowledge and skills needed by health care providers, at different levels of care.
Download or read book European Guidelines for Quality Assurance in Cervical Cancer Screening written by Marc Arbyn and published by . This book was released on 2008 with total page 328 pages. Available in PDF, EPUB and Kindle. Book excerpt: Recoge: 1. Epidemiological guidelines for quality assurance in cervical cancer screening - 2. Methods for screening and diagnosis - 3. Laboratory guidelines and quality assurance practices for cytology - 4. Techniques and quality assurance guidelines for histopathology - 5. Management of abnormal cervical cytology - 6. Key performance indicators - 7. Annexes.
Download or read book Guidelines for the management of symptomatic sexually transmitted infections written by World Health Organization and published by World Health Organization. This book was released on 2021-07-15 with total page 216 pages. Available in PDF, EPUB and Kindle. Book excerpt: The WHO global health sector strategy on sexually transmitted infections, 2016–2021, endorsed by the World Health Assembly in 2016, aims to eliminate STIs as a public health threat by 2030. In 2019, WHO published estimates of new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis. Recent changes in the epidemiology of STIs and progress in prevention, diagnosis and treatment of STIs and HIV have necessitated changes in approaches to STI prevention and management. To address these STIs, the most widely used approach in clinical settings is the syndromic management of STIs. In most resource-limited settings, the syndromic management flow charts are still the standard of care where laboratory diagnosis is not available or is hard to access. The objectives of these guidelines are to provide updated, evidence-informed clinical and practical recommendations on the case management of people with symptoms of STIs; and to support countries in updating their national guidelines for the case management of people with symptoms of STIs. These guidelines include the management of symptomatic infections related to urethral discharge syndrome, including persistent urethral discharge syndrome; vaginal discharge syndrome, including persistent vaginal discharge; anorectal infection; genital ulcer disease syndrome; and lower abdominal pain syndrome. These guidelines are intended for programme managers for STI prevention and control at the national level and the health-care providers at the frontline – primary, secondary and tertiary health care.
Download or read book The Bethesda System for Reporting Cervical Cytology written by Ritu Nayar and published by Springer. This book was released on 2015-04-13 with total page 342 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book offers clear, up-to-date guidance on how to report cytologic findings in cervical, vaginal and anal samples in accordance with the 2014 Bethesda System Update. The new edition has been expanded and revised to take into account the advances and experience of the past decade. A new chapter has been added, the terminology and text have been updated, and various terminological and morphologic questions have been clarified. In addition, new images are included that reflect the experience gained with liquid-based cytology since the publication of the last edition in 2004. Among more than 300 images, some represent classic examples of an entity while others illustrate interpretative dilemmas, borderline cytomorphologic features or mimics of epithelial abnormalities. The Bethesda System for Reporting Cervical Cytology, with its user-friendly format, is a “must have” for pathologists, cytopathologists, pathology residents, cytotechnologists, and clinicians.
Download or read book Who Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention written by World Health Organization and published by . This book was released on 2015-02-20 with total page 55 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytology, colposcopy, biopsy, and histological confirmation of CIN, an alternative method is to use a screen-and-treat approach in which the treatment decision is based on a screening test and treatment is provided soon or, ideally, immediately after a positive screening test. Available screening tests include a human papillomavirus (HPV) test, visual inspection with acetic acid (VIA), and cytology (Pap test). Available treatments include cryotherapy, large loop excision of the transformation zone (LEEP/LLETZ), and cold knife conization (CKC). This guideline provides recommendations for strategies for a screen-and-treat program. It builds upon the existing WHO guidelines: Use of cryotherapy for cervical intraepithelial neoplasia (published in 2011) and on the new WHO guidelines for treatment of cervical intraepithelial neoplasia 2/3 and glandular adenocarcinoma in situ (being published concomitantly with these present guidelines). This guideline is intended primarily for policy-makers, managers, program officers, and other professionals in the health sector who have responsibility for choosing strategies for cervical cancer prevention, at country, regional and district levels. For countries where a cervical cancer prevention and control program already exists, these recommendations were developed to assist decision-makers to determine whether to provide a different screening test followed by a different treatment, or to provide a series of tests followed by an adequate treatment. For countries where such a program does not currently exist, these recommendations can be used to determine which screening test and treatment to provide. In addition to the recommendations, a decision-making flowchart is also proposed in Annex 2 to help program managers choose the right strategy based on the specific country or regional context. Once the strategy has been chosen, the appropriate screen-and-treat flowchart for that strategy can be followed. The flowcharts for all strategies are provided in Annex 3 (specifically for women of negative or unknown HIV status), and Annex 4 (for women of HIV-positive status or unknown HIV status in areas with high endemic HIV infection).
Download or read book A Practical Manual on Visual Screening for Cervical Neoplasia written by R. Sankaranarayanan and published by International Agency for Research on Cancer. This book was released on 2003 with total page 49 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cervical cancer is the second most common cancer among women worldwide. This book serves as a concise teaching manual on visual inspection with acetic acid (VIA) and with Lugol's iodine to train health personnel, especially in developing countries, with the aim to detect this disease in the early pre-invasive phase and save women's lives. These two simple low-technology screening tests based on the ability of the trained health-care personnel to detect acetowhite areas, or yellow non-iodine uptake areas, in the cervical transformation zone are being evaluated as potential alternatives to cervical cytology.
Download or read book Cervical Cancer written by Rajamanickam Rajkumar and published by BoD – Books on Demand. This book was released on 2021-11-17 with total page 148 pages. Available in PDF, EPUB and Kindle. Book excerpt: Although it is preventable and curable, cervical cancer is the fourth most common form of cancer among women worldwide. As such, the World Health Organization adopted a Cervical Cancer Elimination Initiative, which aims to eliminate cervical cancer by 2030. This book discusses plans, programs, strategies, solutions, research, and revolutions necessary to achieve this goal. Chapters cover such topics as epidemiology, HPV vaccination, screening and treatment, and prevention and control.
Download or read book Clinical Gynecology written by Eric J. Bieber and published by Cambridge University Press. This book was released on 2015-04-23 with total page 1127 pages. Available in PDF, EPUB and Kindle. Book excerpt: Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings.
Download or read book Comprehensive Cervical Cancer Control written by World Health Organization and published by . This book was released on 2016-11-11 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for collaboration across programs, organizations and partners. This new guide updates the 2006 edition and includes the recent promising developments in technologies and strategies that can address the gaps between the needs for and availability of services for cervical cancer prevention and control. In the last few years, there has been an emergence of ground-breaking new strategies in cervical cancer prevention and control. Because such strategies require evidence-based evaluation for decision-making in clinical practice and program planning, a World Health Organization (WHO) Steering Committee and a group of invited experts met in Geneva, Switzerland, in September 2010, to ensure that the WHO's guidance on cervical cancer continues to encompass all the relevant technologies and strategies. This edition of the guide has two new chapters: Chapter 2: Essentials for cervical cancer prevention and control programs and Chapter 4: HPV vaccination. One chapter has been newly organized: Chapter 5: Screening and treatment of cervical pre-cancer. All other chapters have been thoroughly updated and edited as needed. This guide aims to assist those responsible for providing services aimed at reducing the burden of cervical cancer on women, their communities and health systems. It focuses on the knowledge, best practices and communication skills needed by health-care providers working at community and primary and secondary levels of care to offer quality services for prevention, screening, treatment and palliative care for cervical cancer: the full continuum of care. The guide is intended primarily for health-care providers in health centers and district hospitals who deal with women's health and/or adolescent's health, but it may also be of interest to community-based and tertiary-level providers. Providers and managers at the sub-national level whose responsibilities may include program planning would be interested in Chapter 2 on program essentials, which covers implementation, monitoring and evaluating, and/or supervising and training other health-care providers. National-level decision-makers will find updated evidence-based information in this guide on what works in cervical cancer prevention and control programs, which may be of use as a basis for updating their own guidelines and protocols.
Download or read book WHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer written by World Health Organization and published by World Health Organization. This book was released on 2020-05-11 with total page 220 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV written by and published by World Health Organization. This book was released on 2021-07-15 with total page 6 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention PDF written by World Health Organization and published by . This book was released on 2014-05-02 with total page 197 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Clinical Preventive Services for Women written by Institute of Medicine and published by National Academies Press. This book was released on 2011-10-27 with total page 249 pages. Available in PDF, EPUB and Kindle. Book excerpt: Women suffer disproportionate rates of chronic disease and disability from some conditions, and often have high out-of-pocket health care costs. The passage of the Patient Protection and Affordable Care Act of 2010 (ACA) provides the United States with an opportunity to reduce existing health disparities by providing an unprecedented level of population health care coverage. The expansion of coverage to millions of uninsured Americans and the new standards for coverage of preventive services that are included in the ACA can potentially improve the health and well-being of individuals across the United States. Women in particular stand to benefit from these additional preventive health services. Clinical Preventive Services for Women reviews the preventive services that are important to women's health and well-being. It recommends that eight preventive health services for women be added to the services that health plans will cover at no cost. The recommendations are based on a review of existing guidelines and an assessment of the evidence on the effectiveness of different preventive services. The services include improved screening for cervical cancer, sexually transmitted infections, and gestational diabetes; a fuller range of contraceptive education, counseling, methods, and services; services for pregnant women; at least one well-woman preventive care visit annually; and screening and counseling for interpersonal and domestic violence, among others. Clinical Preventive Services for Women identifies critical gaps in preventive services for women as well as measures that will further ensure optimal health and well-being. It can serve as a comprehensive guide for federal government agencies, including the Department of Health and Human Services and the Center for Disease Control and Prevention; state and local government agencies; policy makers; health care professionals; caregivers, and researchers.
